Neuralink said the devices would help restore vision and enable people with severe disabilities to move and communicate by decoding brain activity. “We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study," Neuralink said in a tweet. Musk said in 2019 that the company planned to apply for FDA approval for human testing. During a demonstration in December, Musk showed a video of what he called “telepathic typing" from a monkey with a Neuralink brain implant. Clinical testing proving the Neuralink device is safe and effective long-term would be necessary before a brain-computer interface could be introduced to patients, neurotechnology experts have said.

Source: Wall Street Journal May 27, 2023 09:25 UTC